GlaxoSmithKline Pharmaceuticals has announced a board meeting on the financial results for the quarter and half-year.

The board has proposed a final dividend of Rs. 42 per share, up from Rs. 32 last year, pending shareholder approval.

Record and payment dates are set to ensure timely payout.

The company posted a robust consolidated net profit of Rs. 927.58 Cr, significantly higher than last year, with EPS at Rs. 54.76. Strong earnings growth backs the increased dividend, offering good value to shareholders.